BERKELEY, CA (UroToday.com) - Preclinical and epidemiological studies have suggested the use of supplements such as selenium and vitamin E for prostate cancer prevention; however, clinical trials have not demonstrated clear benefit in patients.
In this study we demonstrate that many men who visit urology clinics use selenium and vitamin E despite the lack of clinical support for chemoprevention. Education status is a predictor for their use; more men with a higher education attributed their use of selenium to urologist advice (24%) and with a lower education attributed their use of selenium to naturopath/homeopath advice (28%).
This information may aid in addressing the needs of the diverse patient population using these supplements for the prevention of prostate cancer.
Written by:
Jennifer A. Locke, PhD as part of Beyond the Abstract on UroToday.com. This initiative offers a method of publishing for the professional urology community. Authors are given an opportunity to expand on the circumstances, limitations etc... of their research by referencing the published abstract.
MD candidate 2013
University of Toronto
Email:
Prevalence and predictors of selenium and vitamin E supplementation in a urology population - Abstract
More Information about Beyond the Abstract